Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Am J Transplant ; 16(9): 2734-40, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27000433

RESUMO

A large number of human polyomaviruses have been discovered in the last 7 years. However, little is known about the clinical impact on vulnerable immunosuppressed patient populations. Blood, urine, and respiratory swabs collected from a prospective, longitudinal adult kidney transplant cohort (n = 167) generally pre-operatively, at day 4, months 1, 3, and 6 posttransplant, and at BK viremic episodes within the first year were screened for 12 human polyomaviruses using real-time polymerase chain reaction. Newly discovered polyomaviruses were most commonly detected in the respiratory tract, with persistent shedding seen for up to 6 months posttransplant. Merkel cell polyomavirus was the most common detection, but was not associated with clinical symptoms or subsequent development of skin cancer or other skin abnormalities. In contrast, KI polyomavirus was associated with respiratory disease in a subset of patients. Human polyomavirus 9, Malawi polyomavirus, and human polyomavirus 12 were not detected in any patient samples.


Assuntos
Rejeição de Enxerto/virologia , Falência Renal Crônica/cirurgia , Transplante de Rim , Infecções por Polyomavirus/virologia , Polyomavirus/isolamento & purificação , Sistema Respiratório/virologia , Infecções Tumorais por Vírus/virologia , Adolescente , Adulto , Idoso , Austrália/epidemiologia , DNA Viral/genética , Feminino , Seguimentos , Taxa de Filtração Glomerular , Rejeição de Enxerto/epidemiologia , Sobrevivência de Enxerto , Humanos , Hospedeiro Imunocomprometido , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Polyomavirus/genética , Infecções por Polyomavirus/epidemiologia , Prognóstico , Estudos Prospectivos , Fatores de Risco , Infecções Tumorais por Vírus/epidemiologia , Adulto Jovem
2.
Endocr Relat Cancer ; 16(2): 537-48, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19218280

RESUMO

The imprinted gene, neuronatin (NNAT), is one of the most abundant transcripts in the pituitary and is thought to be involved in the development and maturation of this gland. In a recent whole-genome approach, exploiting a pituitary tumour cell line, we identified hypermethylation associated loss of NNAT. In this report, we determined the expression pattern of NNAT in individual cell types of the normal gland and within each of the different pituitary adenoma subtypes. In addition, we determined associations between expression and CpG island methylation and used colony forming efficiency assays (CFE) to gain further insight into the tumour-suppressor function of this gene. Immunohistochemical (IHC) co-localization studies of normal pituitaries showed that each of the hormone secreting cells (GH, PRL, ACTH, FSH and TSH) expressed NNAT. However, 33 out of 47 adenomas comprising, 11 somatotrophinomas, 10 prolactinomas, 12 corticotrophinomas and 14 non-functioning tumours, irrespective of subtype failed to express either NNAT transcript or protein as determined by quantitative real-time RT-PCR and IHC respectively. In normal pituitaries and adenomas that expressed NNAT the promoter-associated CpG island showed characteristics of an imprinted gene where approximately 50% of molecules were densely methylated. However, in the majority of adenomas that showed loss or significantly reduced expression of NNAT, relative to normal pituitaries, the gene-associated CpG island showed significantly increased methylation. Induced expression of NNAT in transfected AtT-20 cells significantly reduced CFE. Collectively, these findings point to an important role for NNAT in the pituitary and perhaps tumour development in this gland.


Assuntos
Metilação de DNA , Proteínas de Membrana/genética , Proteínas do Tecido Nervoso/genética , Hipófise/patologia , Neoplasias Hipofisárias/genética , Regiões Promotoras Genéticas/genética , Animais , Ilhas de CpG , Inativação Gênica , Humanos , Técnicas Imunoenzimáticas , Perda de Heterozigosidade , Proteínas de Membrana/metabolismo , Camundongos , Proteínas do Tecido Nervoso/metabolismo , Hipófise/metabolismo , Neoplasias Hipofisárias/metabolismo , Neoplasias Hipofisárias/patologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células Tumorais Cultivadas
3.
Pediatrics ; 75(2): 299-303, 1985 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3881728

RESUMO

Two outbreaks of group A streptococcal abscesses following receipt of diphtheria-tetanus toxoid-pertussis (DTP) vaccine from different manufacturers were reported to the Centers for Disease Control (CDC) in 1982. The clustering of the immunization times of cases, the isolation of the same serotype of Streptococcus from all cases in each outbreak, and the absence of reported abscesses associated with receipt of the same lots of vaccine in other regions of the country, suggest that each outbreak was probably caused by contamination of a single 15-dose vial of vaccine. The preservative thimerosal was present within acceptable limits in unopened vials from the same lot of DTP vaccine in each outbreak. Challenge studies indicate that a strain of Streptococcus from one of the patients can survive up to 15 days in DTP vaccine at 4 degrees C. Contamination of vials during manufacturing would have required survival of streptococci for a minimum of 8 months. Preservatives in multidose vaccine vials do not prevent short-term bacterial contamination. Options to prevent further clusters of streptococcal abscesses are discussed. The only feasible and cost-effective preventive measure now available is careful attention to sterile technique when administering vaccine from multidose vials.


Assuntos
Abscesso/epidemiologia , Toxoide Diftérico/efeitos adversos , Surtos de Doenças/epidemiologia , Vacina contra Coqueluche/efeitos adversos , Infecções Estreptocócicas/epidemiologia , Toxoide Tetânico/efeitos adversos , Abscesso/economia , Abscesso/etiologia , Criança , Vacina contra Difteria, Tétano e Coqueluche , Combinação de Medicamentos/efeitos adversos , Contaminação de Medicamentos , Georgia , Humanos , Oklahoma , Infecções Estreptocócicas/economia , Infecções Estreptocócicas/etiologia , Streptococcus pyogenes/crescimento & desenvolvimento , Fatores de Tempo
4.
J Mol Endocrinol ; 42(6): 461-8, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19208779

RESUMO

Investigation of the epigenome of sporadic pituitary tumours is providing a more detailed understanding of aberrations that characterise this tumour type. Early studies, in this and other tumour types adopted candidate-gene approaches to characterise CpG island methylation as a mechanism responsible for or associated with gene silencing. However, more recently, investigators have adopted approaches that do not require a priori knowledge of the gene and transcript, as example differential display techniques, and also genome-wide, array-based approaches, to 'uncover' or 'unmask' silenced genes. Furthermore, through use of chromatin immunoprecipitation as a selective enrichment technique; we are now beginning to identify modifications that target the underlying histones themselves and that have roles in gene-silencing events. Collectively, these studies provided convincing evidence that change to the tumour epigenome are not simply epiphenomena but have functional consequences in the context of pituitary tumour evolution. Our ability to perform these types of studies has been and is increasingly reliant upon technological advances in the genomics and epigenomics arena. In this context, other more recent advances and developing technologies, and, in particular, next generation or flow cell re-sequencing techniques offer exciting opportunities for our future studies of this tumour type.


Assuntos
Adenoma/genética , Epigênese Genética , Neoplasias Hipofisárias/genética , Metilação de DNA , Inativação Gênica , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA